Nectar Lifesciences Shareholding Pattern
- Market cap
- ₹201 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹7.44 – ₹13.95
As of Jun 2026, promoters held 48.50% of Nectar Lifesciences, foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%.
Source: Shareholding patterns filed with the stock exchanges (company filings). Data as of 9 October 2026. How this data is compiled.
Nectar Lifesciences shareholding pattern — frequently asked questions
What is the promoter holding in Nectar Lifesciences?
Promoters held 48.50% of Nectar Lifesciences as of Jun 2026.
How much do FIIs hold in Nectar Lifesciences?
Foreign institutional investors held 18.40% of Nectar Lifesciences as of Jun 2026.
How much do domestic institutions hold in Nectar Lifesciences?
Domestic institutional investors, including mutual funds and insurers, held 14.20% of Nectar Lifesciences as of Jun 2026; mutual funds alone held 8.50%.
Who owns Nectar Lifesciences?
As of Jun 2026, Nectar Lifesciences' shareholders were promoters (48.50%), foreign institutional investors 18.40%, domestic institutions 14.20% and the public 18.90%, as filed with the stock exchanges.
Same Data For Peers
Trade Nectar Lifesciences With ATS
Track NECLIFE live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.